Q2 revenue rises 21%, profit falls 21%; tax cases highlighted

Emphasis Of MatterRevenue Growth 20pctEbitda Margin CompressionResults RestatedResults View source PDF Explain this filing

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.8%Reaction day

₹2310.00

prior close

₹2250.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.5%-2.3% vs market

Pharmaceuticals peers, median of 156sector-0.0%-1.8% vs sector

On the reaction day the stock moved 2.3 pts less than Nifty Midcap 150 and 1.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.7

10m

+0.8

15m

+0.9

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.8+0.5-2.3-0.0-1.8

Next day

-3.1+0.9-4.0-0.7-2.4

-3.9+1.4-5.3-0.9-3.0

-1.1+2.1-3.2+0.1-1.2

-2.0+1.8-3.8+0.2-2.2

-1.6+1.9-3.5+0.0-1.6

-3.7+1.9-5.6-0.3-3.4

15d

-2.6+2.2-4.7-1.6-0.9

-5.3-0.4-4.9-5.3+0.0

-0.2+3.1-3.3-2.9+2.7

-9.8+1.6-11.4-7.3-2.5

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 consolidated revenue rose 20.8% year on year to Rs 3,697.16 crore, but profit after tax fell 21.3% to Rs 520.18 crore and operating margin narrowed to about 25% from 27.8%. Six-month operating cash inflow was Rs 1,321.07 crore. The review was unmodified, but auditors highlighted tax cases involving Rs 1,825.66 crore of disputed expenditure, which management says has no material impact. Prior figures were restated after an amalgamation.

Likely market impact

Revenue growth and cash generation are positive, but the profit decline, narrower margin and pending tax cases may weigh on the stock.